SCHEMBL25609261

SCHEMBL25609261

c1ccc(-c2nc(-c3ccc4ccccc4c3)nc(-c3nc(-c4ccccc4)nc(-c4ccccc4-c4ccc5ccc6ccc7nn(-c8ccccc8)nc7c6c5c4)n3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.37
MET P08581 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.34
KDM4E B2RXH2 3/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
KMT2A Q03164 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NPC1 O15118 2/20 0.31
MAPT P10636 2/20 0.31
RAB9A P51151 2/20 0.31
STAT1 P42224 1/20 0.31
GRM5 P41594 1/20 0.31
HPGD P15428 1/20 0.31
LMNA P02545 1/20 0.30
RECQL P46063 1/20 0.30
HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25609264 0.94 ALOX5 (0.37) ALOX5METABCG2KDM4EMEN1
SCHEMBL25609263 0.94 ABCG2 (0.40) ALOX5ABCG2KDM4EMEN1ALDH1A1
SCHEMBL25548270 0.94 ALOX5 (0.39) ALOX5METABCG2KDM4EMEN1
SCHEMBL25548185 0.93 ABCG2 (0.40) ALOX5ABCG2KDM4EMEN1ALDH1A1
SCHEMBL25548277 0.93 ALOX5 (0.38) ALOX5METABCG2KDM4EMEN1
SCHEMBL25548276 0.93 ABCG2 (0.40) ALOX5ABCG2KDM4EMEN1ALDH1A1
SCHEMBL25548143 0.93 ALOX5 (0.42) ALOX5METABCG2KDM4EMEN1
SCHEMBL25609262 0.92 ALOX5 (0.35) ALOX5METABCG2KDM4EMEN1
SCHEMBL25548278 0.91 ALOX5 (0.35) ALOX5METABCG2KDM4EMEN1
SCHEMBL25548144 0.91 ALOX5 (0.43) ALOX5KDM4EMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167089-A1 ORGANIC MATERIAL COMPOSITION AND APPLICATIONS THEREOF PIEZO1, VCL, VDAC3 ALOX5 977/4885MET 4617/4885ABCG2 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.